Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Looks to Streamline Rules for New Drug Cocktails
WSJ Online
Thursday, March 18, 2010 - 10:24am
tags:
FDA, drug cocktails
Biopharma R&D rises 2% in '09 despite recession
Fierce Biotech
Thursday, March 18, 2010 - 10:19am
tags:
biotech, R&D
J&J, Sanofi, Pfizer Speed Testing for New Tuberculosis Drug
Bloomberg
Thursday, March 18, 2010 - 10:17am
tags:
JNJ, Pfizer, Sanofi, tuberculosis
Roche to Introduce at Least Six New Medicines By 2015
Bloomberg
Thursday, March 18, 2010 - 10:16am
tags:
Roche, pipelines, oncology
The Alpharma Morphine Painkiller Probe Ain't Over: "Unnamed Defendant" Still Twists in the Wind
BNET Pharma
Thursday, March 18, 2010 - 10:14am
tags:
King, Kadian, Alpharma, settlements
Sequenom: Missing Analysts' Expectations by Five Cents Caused a Sell-Off?
Seeking Alpha
Thursday, March 18, 2010 - 10:13am
tags:
Sequenom
Glaxo up as Novartis drops generic Advair in U.S.
Reuters
Thursday, March 18, 2010 - 10:12am
tags:
Novartis, GSK, generics, Advair, Sandoz
Pay-To-Delay Ban Dropped From Healthcare Reform
Pharmalot
Thursday, March 18, 2010 - 10:10am
tags:
healthcare reform, healthcare bill, pay-for-delay
Alzheimer Drug Test Result From J&J May Be Pushed Back to 2012
Bloomberg
Thursday, March 18, 2010 - 10:09am
tags:
Alzheimer's disease, JNJ, bapineuzumab
Teva to buy Ratiopharm for nearly $5 billion
Yahoo/Reuters
Thursday, March 18, 2010 - 10:08am
tags:
Teva Pharmaceuticals, Ratiopharm, M&A, Pfizer, Actavis, generics
More Delays on MannKind's Inhaled Insulin: The Pros and Cons
BNET Pharma
Thursday, March 18, 2010 - 8:15am
tags:
MannKind, inhaled insulin, diabetes, Afrezza
Pfizer: Analysts Bullish on Cheap Stock
TheStreet.com
Thursday, March 18, 2010 - 7:41am
tags:
Pfizer
Biogen: Now 42 Cases Of Brain Infection In Tysabri Patients
WSJ Online
Thursday, March 18, 2010 - 7:28am
tags:
Biogen Idec, Elan, Tysabri, MS, PML
Teva Reportedly Wins Bid for Ratiopharm
TheStreet.com
Thursday, March 18, 2010 - 7:16am
tags:
Teva Pharmaceuticals, Pfizer, Actavis, Ratiopharm, M&A
What the Eli Lilly Theft Means for Pharma
Minyanville
Thursday, March 18, 2010 - 7:15am
tags:
drug theft, Eli Lilly
The Promise Behind Incyte
Minyanville
Thursday, March 18, 2010 - 7:13am
tags:
Incyte, rheumatoid arthritis
Scripts going unfilled at 'unprecedented' rate
Medical Marketing and Media
Wednesday, March 17, 2010 - 11:30am
tags:
prescription data
Fuzeon’s fizzle saps Trimeris’ earnings
Bizjournals.com
Wednesday, March 17, 2010 - 11:29am
tags:
earnings, Fuzeon, Trimeris
Abraxis' Abraxane meets lung cancer study goal
Yahoo/AP
Wednesday, March 17, 2010 - 11:28am
tags:
Abraxane, companies, lung cancer
Three-way Ratiopharm auction comes to head: sources
Yahoo/Reuters
Wednesday, March 17, 2010 - 11:21am
tags:
Ratiopharm, Pfizer, Teva Pharmaceuticals, Actavis, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.